Herbal medicinal products in the European Union - AESGP
Herbal medicinal products in the European Union - AESGP
Herbal medicinal products in the European Union - AESGP
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Ireland<br />
The Irish Medic<strong>in</strong>es Board (IMB) considers that ESCOP and WHO monographs and W H O<br />
Guidel<strong>in</strong>es have a support<strong>in</strong>g role.<br />
Italy<br />
The M<strong>in</strong>istry of Health has so far not considered ESCOP and WHO monographs and W H O<br />
Guidel<strong>in</strong>es as reference tools for <strong>medic<strong>in</strong>al</strong> <strong>products</strong>. It is await<strong>in</strong>g <strong>the</strong> results of <strong>the</strong> Ad Hoc<br />
Work<strong>in</strong>g Group on <strong>Herbal</strong> Medic<strong>in</strong>al Products. It would not oppose <strong>the</strong> development of<br />
<strong>European</strong> core-SPCs.<br />
Luxembourg<br />
ESCOP and WHO monographs would <strong>in</strong> <strong>the</strong>ory be acceptable as references, but at present<br />
<strong>the</strong>re is no assessment specific to herbal <strong>medic<strong>in</strong>al</strong> <strong>products</strong>.<br />
The Ne<strong>the</strong>rlands<br />
Monographs on <strong>in</strong>dications or cl<strong>in</strong>ical use are at present not used.<br />
Portugal<br />
All this material is regarded as useful, but has not yet had any impact on <strong>the</strong> current<br />
assessment process.<br />
Spa<strong>in</strong><br />
ESCOP and WHO monographs are used as bibliographic references.<br />
Sweden<br />
ESCOP monographs may be used along with o<strong>the</strong>r documents, but are not alone accepted as<br />
sufficient support for approval (i.e., <strong>the</strong>y cannot be <strong>the</strong> sole source). WHO monographs are<br />
accepted as contribut<strong>in</strong>g support <strong>in</strong> <strong>the</strong> assessment process, but so far <strong>the</strong>re has been no<br />
experience with <strong>the</strong>se monographs. The monographs are considered as not be<strong>in</strong>g complete<br />
enough. The “WHO Guidel<strong>in</strong>es on <strong>the</strong> Assessment of <strong>Herbal</strong> Medic<strong>in</strong>es” have been partially<br />
implemented.<br />
United K<strong>in</strong>gdom<br />
ESCOP and WHO monographs are regarded as a useful summary, but <strong>the</strong> orig<strong>in</strong>al<br />
references are needed.<br />
Summary<br />
ESCOP as well as WHO monographs are regarded as useful summaries of bibliographic<br />
data <strong>in</strong> many countries. O<strong>the</strong>r sources such as <strong>European</strong> Core-SPCs as well as fur<strong>the</strong>r results<br />
of <strong>the</strong> EMEA Ad hoc Work<strong>in</strong>g Group on <strong>Herbal</strong> Medic<strong>in</strong>al Products are considered desirable<br />
by many health authorities for <strong>the</strong> assessment of herbal <strong>medic<strong>in</strong>al</strong> <strong>products</strong>.<br />
VII.2.6 Existence of a Category for Well-Known Plants<br />
The authorities were asked whe<strong>the</strong>r <strong>the</strong>re is a specific category <strong>in</strong> which herbal <strong>medic<strong>in</strong>al</strong><br />
<strong>products</strong> conta<strong>in</strong><strong>in</strong>g well-known plants can be classified.<br />
In <strong>the</strong> follow<strong>in</strong>g countries, well-known plants can be <strong>in</strong>cluded <strong>in</strong> <strong>the</strong> follow<strong>in</strong>g categories:<br />
Country Categories<br />
Austria List accord<strong>in</strong>g to Section 17a of <strong>the</strong> Medic<strong>in</strong>es Law [AT 2,3]<br />
Belgium Lists of <strong>the</strong> M<strong>in</strong>isterial Circular (“Circulaire m<strong>in</strong>istérielle”) [B 2]<br />
France Agency Instructions (“Cahiers de l’Agence No.3”) [F 4]<br />
47